Daniel M. Bendheim, Executive VP, Corporate Strategy at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 5,000 shares at $32.31 ($162K) on 2019-01-08, disclosed to the SEC on 2019-01-10.
Open-market sale of $162k PAHC by Executive VP, Corporate Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.31 | 2,500 | $81K | 49.8% |
| 2 | $32.54 | 2,500 | $81K | 50.2% |
| Total | $32.42 avg | 5,000 | $162K | 100% |
| Filing → |
| PAHC | SELL | 2019-01-18 | $242K | — | Filing → |
| PAHC | SELL | 2019-01-07 | $238K | — | Filing → |
| PAHC | SELL | 2018-09-14 | $111K | — | Filing → |